Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer

NCT00487786 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: OGX-427
DRUG: Docetaxel

Sponsor

Achieve Life Sciences